课题基金 / 基金详情

Characterization of V(D)J cleavage and repair complexes

Characterization of V(D)J cleavage and repair complexes
V(D)J 裂解和修复复合物的表征
批准号:
7647516
负责人:
Patrick C. Swanson
金额:
$28.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2010-07-31

项目摘要

项目成果

Patrick C. Swanson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
B and T lymphocytes form the foundation of our adaptive immune system and have the unique capacity for antigen-specific recognition mediated by immunoglobulins (Igs) and T cell receptors (TCRs), respectively. The Ig and TCR genes are unique because the exons encoding the variable domains of Igs and TCRs must be assembled from discrete gene segments by somatic DNA rearrangement to gain functionality. This rearrangement process, called V(D)J recombination, is initiated when two proteins, called RAG1 and RAG2, bridge two antigen receptor gene segments through protein-DNA interactions with a recombination signal sequence (RSS) that flanks each gene segment, and then cleaves the DNA to separate the RSS from the gene coding segment (the ¿cleavage phase¿). Subsequently, the four DNA ends are reorganized, processed, and rejoined via the non-homologous end-joining (NHEJ) DNA repair pathway to form a ¿signal joint¿ from two RSS ends and a ¿coding joint¿ from two coding ends (the ¿joining phase¿). While the basic steps of V(D)J recombination are fairly well understood, many important details remain unclear, particularly where the cleavage and joining phases intersect. For example, some evidence suggests that the RAG proteins play an active role in guiding the transfer of DNA ends to the NHEJ machinery, but a mechanistic understanding of this process is lacking. Part of the difficulty in elucidating the interplay between the two phases of V(D)J recombination may be due to the historical use of truncated, catalytically active ¿core¿ forms of RAG1 and RAG2 in biochemical assays for these reactions, which may be unable to fully stabilize association with regulatory and NHEJ factors. We have developed strategies to purify full-length RAG proteins that increase their suitability for biochemical analysis, and used these RAG preparations to obtain evidence that full-length RAG1 associates with the Ku70/Ku80 complex involved in NHEJ, possibly through novel interaction partners. To gain additional insight into molecular mechanisms that control and connect the cleavage and joining phases of V(D)J recombination, we propose to: (i) examine the mechanisms underlying a novel form of structurespecific, rather than sequence-specific, DNA cleavage by the RAG proteins; (ii) determine how the ¿non-core¿ portions of the RAG proteins contribute to post-cleavage complex stability, influence DNA repair, and modulate the enzymatic activity and protein-DNA contacts in discrete RAG complexes assembled on DNA substrates containing a pair of RSSs; (iii) characterize newly identified factors found to interact with full-length RAG1 for their biological activity and physiological importance in V(D)J recombination. Greater knowledge of how the RAG proteins initiate cleavage and guide the repair the RAG-mediated DNA breaks will improve our understanding of the mechanisms contributing to impaired and aberrant V(D)J recombination that is suspected to underlie certain forms of immunodeficiency and lymphoid malignancy, respectively.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel form of light chain gene replacement
  • 批准号:
    10330601
  • 项目类别:
  • 资助金额:
    $18.19万
  • 财政年份:
    2021
  • 负责人:
    Patrick C. Swanson
  • 依托单位:
A novel form of light chain gene replacement
  • 批准号:
    10191435
  • 项目类别:
  • 资助金额:
    $21.83万
  • 财政年份:
    2021
  • 负责人:
    Patrick C. Swanson
  • 依托单位:
Role of RACK1 in RAG1 degradation and B cell development
  • 批准号:
    10430247
  • 项目类别:
  • 资助金额:
    $18.19万
  • 财政年份:
    2021
  • 负责人:
    Patrick C. Swanson
  • 依托单位:
Role of RACK1 in RAG1 degradation and B cell development
  • 批准号:
    10302865
  • 项目类别:
  • 资助金额:
    $21.83万
  • 财政年份:
    2021
  • 负责人:
    Patrick C. Swanson
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究